Sign In
Buy LLY
$1,131.42
+6.15 (+0.547%)
At Close: Jun 05, 2026
2 Blue Chip Stocks To Watch In Late September 2024
09:54am, Tuesday, 24'th Sep 2024
Blue chip stocks to watch this week.
Eli Lilly's Alzheimer's treatment Kisunla wins approval in Japan
06:53am, Tuesday, 24'th Sep 2024
Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer's is the most common form of dementia, accounting for more than 67% of cases
Eli Lilly's Alzheimer's drug approved in Japan
06:06am, Tuesday, 24'th Sep 2024
Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment option after Eisai and Biogen's Leqembi received t
Lilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's Disease
06:00am, Tuesday, 24'th Sep 2024
Japan is the second major market where Kisunla has received approval Kisunla was first approved in the United States in July 2024 INDIANAPOLIS , Sept. 24, 2024 /PRNewswire/ -- The Ministry of Health,
Investing in This Healthcare Stock Could Be Like Catching Nvidia at the Dawn of the AI Boom
08:15am, Sunday, 22'nd Sep 2024
Since ChatGPT was released almost two years ago, shares of Nvidia have soared over 500%. Outside of the tech sector, new diabetes and obesity treatments have revved up the pharma space.
Eli Lilly Is Finally Cheap, Warranting An Upgrade To Buy
10:00am, Saturday, 21'st Sep 2024
Eli Lilly's long-term growth prospects have been secured by the improved supply in H2'24 and the incoming capacity additions from H1'25 onwards. This is on top of the introduction of its D2C channel f
Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)
09:53am, Saturday, 21'st Sep 2024
Eli Lilly has become a household name thanks to breakthrough diabetes and obesity care medicines. The stock has trounced the broader market over the past year, and shares have become a bit pricey.
Our Top 10 Dividend Growth Stocks - September 2024
09:00am, Saturday, 21'st Sep 2024
This article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and
Netflix, Eli Lilly Lead 5 Fast Growers Near Buy Points
08:51am, Saturday, 21'st Sep 2024
Netflix and Eli Lilly lead this weekend's list of five stocks near buy points that are all enjoying rapid sales growth.
Eli Lilly: Sticking With A $1000 Target Ahead Of Q3 Earnings, New Trading Range
04:31am, Saturday, 21'st Sep 2024
Eli Lilly has surged 58% in 2024, driven by breakthrough weight-loss drugs and strong earnings, with shares now trading above $900. Despite valuation concerns, LLY's high growth rate and reliable earn
Eli Lilly: I Admit Defeat As I Understated Its Growth Prospects (Upgrade)
11:30am, Friday, 20'th Sep 2024
Eli Lilly has proved me wrong again, outperforming the S&P 500 since my previous update. Lilly is gaining share and achieving breakthroughs in the US commercial market. Its pipeline is growing, potent
Prediction: This Will Be the Biggest Pharma Stock in 10 Years
09:15am, Thursday, 19'th Sep 2024
24/7 Wall St. Insights Eli Lilly and Co. (NYSE: LLY) is the clear frontrunner to be the largest pharmaceutical stock in 2034.
1 Unstoppable Stock That Could Join the $1 Trillion Club in 2025
05:50am, Thursday, 19'th Sep 2024
Most of the stocks in the trillion-dollar club are tech stocks. One of the biggest names in healthcare, Eli Lilly, could join those ranks within the next few months.
Prediction: This Will be Eli Lilly's Next Big Move.
04:10am, Thursday, 19'th Sep 2024
Eli Lilly's stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring sales thanks to its dominance in the high-growth weight loss drug market.
Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?
04:01pm, Tuesday, 17'th Sep 2024
Investors can buy LLY stock based on its strong overall financial performance and robust drug pipeline.
